General Announcement::Corporate Action

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
04-Apr-2022 20:56:25
Status
New
Announcement Sub Title
Corporate Action
Announcement Reference
SG220404OTHRSVBJ
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
04/04/2022 00:00:00
Description (Please provide a detailed description of the event in the box below)
Intimation of Operations Committee Meeting to authorize the repurchase of outstanding U.S.$200,000,000 2.00 per cent. Resettable Onward Starting Equity-linked Securities Due 2022 ( Bonds ) by Glenmark Pharmaceuticals Limited (the Company ) and issuance of the Notice of Early Redemption by the Company to the holders of the Bonds

Attachments

SGX_04.04.2022.pdf
Total size =637K